BRIEF-Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement

Reuters

Nov 22, 2023

Nov 22 (Reuters) - Bellicum Pharmaceuticals Inc

* BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION AND DISSOLUTION OF CO

* BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET PURCHASE AGREEMENT

* BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC WILL ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS

* BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC WILL PAY TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH & WILL ASSUME CERTAIN RELATED LIABILITIES

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2385654719"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2385654719\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2385654719?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-11-22 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2385654719","market":"us","top_or_hot":-1,"title":"BRIEF-Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement","media":"Reuters","content":"<html><body><p>Nov 22 (Reuters) - Bellicum Pharmaceuticals Inc</p><p> :</p><p>   * BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION AND DISSOLUTION OF CO</p><p>   * BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET PURCHASE AGREEMENT</p><p>   * BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC WILL ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS</p><p>   * BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC WILL PAY TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH &amp; WILL ASSUME CERTAIN RELATED LIABILITIES</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-11-22 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Nov 22 (Reuters) - Bellicum Pharmaceuticals Inc</p><p> :</p><p>   * BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION AND DISSOLUTION OF CO</p><p>   * BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET PURCHASE AGREEMENT</p><p>   * BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC WILL ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS</p><p>   * BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC WILL PAY TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH &amp; WILL ASSUME CERTAIN RELATED LIABILITIES</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2385654719","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2385654719","pubTimestamp":1700660058,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 22  - Bellicum Pharmaceuticals Inc :   * BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION AND DISSOLUTION OF CO   * BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET PURCHASE AGREEMENT   * BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC WILL ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS   * BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC WILL PAY TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH & WILL ASSUME CERTAIN RELATED LIABILITIESFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4578":"CAR-T"},"translate_title":"Bellicum Pharmaceuticals表示，董事会批准清算和解散与批准资产购买协议相关的Co","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLCM":1},"content_text":"Nov 22 (Reuters) - Bellicum Pharmaceuticals Inc :   * BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION AND DISSOLUTION OF CO   * BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET PURCHASE AGREEMENT   * BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC WILL ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS   * BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC WILL PAY TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH & WILL ASSUME CERTAIN RELATED LIABILITIESFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}